Product

Company

Clareo Health | Diazoxide Choline in Hypertriglyceridemia

NCT00696475·12 sites·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Essentialis, Inc.

With

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

Fasting glucose ≥ 126 mg/dL
Glycosylated hemoglobin (HbA1c) \> 6.5%
LDL cholesterol \> 190 mg/dL
Known history of type I and II DM
Known history of type I and III hyperlipidemia
Weight change \> 3 kg between screening and baseline visits
Pregnancy or intention to become pregnant
Presence of significant underlying conditions that may interfere with the assessments of the study drug

The record

StatusCompleted

PhasePhase 2

Taking part80

StartedJun 2008

UpdatedNov 8, 2010

Conditions

Where12

National Research Institute
Los Angeles, California, United States
Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
Allied Research International/Cetero Research
Miami Gardens, Florida, United States